CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise 10b5-1 | +17,600 | $15.90 | $280K | 121,213 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −11,125 | $47.89 | $533K | 110,088 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −6,475 | $48.66 | $315K | 103,613 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −17,600 | 0 | ||
| 2025-12-05 | Balice-Gordon Rita J. Director | Sale | −3,650 | $47.03 | $172K | 52,629 |
| 2025-11-12 | Karnani Vikram President and CEO | Shares withheld for taxes | −8,983 | $47.35 | $425K | 96,989 |
| 2025-11-12 | Fallon John A. Director | Option exercise | +15,000 | $16.49 | $247K | 79,634 |
| 2025-11-12 | Fallon John A. Director | Option exercise | +19,853 | $9.33 | $185K | 99,487 |
| 2025-11-12 | Fallon John A. Director | Sale | −34,853 | $47.21 | $1.6M | 64,634 |
| 2025-11-12 | Fallon John A. Director | Option exercise · Stock Option (Right to Purchase) | −15,000 | 0 | ||
| 2025-11-12 | Fallon John A. Director | Option exercise · Stock Option (Right to Purchase) | −19,853 | 0 | ||
| 2025-11-06 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −25,142 | $40.38 | $1.0M | 131,525 |
| 2025-11-06 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −4,858 | $41.28 | $201K | 126,667 |
| 2025-08-29 | Smith Thomas B EVP and Chief Medical Officer | Sale | −17,478 | $38.42 | $672K | 70,264 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise 10b5-1 | +16,389 | $21.34 | $350K | 120,002 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −16,389 | $38.21 | $626K | 103,613 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −16,389 | 0 | ||
| 2025-08-15 | SANTINI GINO Director | Option exercise | +15,000 | $13.45 | $202K | 100,447 |
| 2025-08-15 | SANTINI GINO Director | Sale | −5,405 | $37.19 | $201K | 95,042 |
| 2025-08-15 | SANTINI GINO Director | Option exercise · Stock Option (Right to Purchase) | −15,000 | 0 |
Page 3 of 24 · 462 trades